The intake of higher doses of resveratrol did not affect the circulating levels of glucose, insulin, glycosylated hemoglobin, and glucagon-like peptide-1 in type 2 diabetic patients [47,48], as well as glucose tolerance and insulin sensitivity in older glucose-intolerant adults [71]. The gene discussed is INS; the disease is type 2 diabetes mellitus.